GB754885A - Recovery of heparin - Google Patents
Recovery of heparinInfo
- Publication number
- GB754885A GB754885A GB18577/54A GB1857754A GB754885A GB 754885 A GB754885 A GB 754885A GB 18577/54 A GB18577/54 A GB 18577/54A GB 1857754 A GB1857754 A GB 1857754A GB 754885 A GB754885 A GB 754885A
- Authority
- GB
- United Kingdom
- Prior art keywords
- heparin
- protein
- solution
- salt
- precipitated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 229960002897 heparin Drugs 0.000 title abstract 12
- 229920000669 heparin Polymers 0.000 title abstract 12
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 title abstract 11
- 238000011084 recovery Methods 0.000 title 1
- 239000000243 solution Substances 0.000 abstract 10
- 235000018102 proteins Nutrition 0.000 abstract 8
- 102000004169 proteins and genes Human genes 0.000 abstract 8
- 108090000623 proteins and genes Proteins 0.000 abstract 8
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 abstract 7
- 150000003839 salts Chemical class 0.000 abstract 7
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 abstract 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 5
- 238000000034 method Methods 0.000 abstract 5
- 239000000203 mixture Substances 0.000 abstract 4
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 abstract 3
- 235000019441 ethanol Nutrition 0.000 abstract 3
- 239000011780 sodium chloride Substances 0.000 abstract 3
- 150000001242 acetic acid derivatives Chemical class 0.000 abstract 2
- 239000002253 acid Substances 0.000 abstract 2
- 229910052783 alkali metal Inorganic materials 0.000 abstract 2
- 150000001340 alkali metals Chemical class 0.000 abstract 2
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 abstract 2
- 229910052921 ammonium sulfate Inorganic materials 0.000 abstract 2
- 239000001166 ammonium sulphate Substances 0.000 abstract 2
- 235000011130 ammonium sulphate Nutrition 0.000 abstract 2
- 239000007864 aqueous solution Substances 0.000 abstract 2
- 238000000502 dialysis Methods 0.000 abstract 2
- 238000010438 heat treatment Methods 0.000 abstract 2
- 230000020477 pH reduction Effects 0.000 abstract 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 abstract 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 abstract 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 abstract 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 abstract 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 abstract 1
- 150000007513 acids Chemical class 0.000 abstract 1
- 239000003513 alkali Substances 0.000 abstract 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 abstract 1
- 229910001615 alkaline earth metal halide Inorganic materials 0.000 abstract 1
- 150000001342 alkaline earth metals Chemical class 0.000 abstract 1
- 150000001450 anions Chemical class 0.000 abstract 1
- 239000001639 calcium acetate Substances 0.000 abstract 1
- 235000011092 calcium acetate Nutrition 0.000 abstract 1
- 229960005147 calcium acetate Drugs 0.000 abstract 1
- 239000001110 calcium chloride Substances 0.000 abstract 1
- 229910001628 calcium chloride Inorganic materials 0.000 abstract 1
- 235000011148 calcium chloride Nutrition 0.000 abstract 1
- 239000005018 casein Substances 0.000 abstract 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 abstract 1
- 235000021240 caseins Nutrition 0.000 abstract 1
- 150000001860 citric acid derivatives Chemical class 0.000 abstract 1
- 230000015271 coagulation Effects 0.000 abstract 1
- 238000005345 coagulation Methods 0.000 abstract 1
- 239000000706 filtrate Substances 0.000 abstract 1
- 238000001914 filtration Methods 0.000 abstract 1
- 150000004820 halides Chemical class 0.000 abstract 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Natural products OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 230000007935 neutral effect Effects 0.000 abstract 1
- 150000007524 organic acids Chemical class 0.000 abstract 1
- 235000005985 organic acids Nutrition 0.000 abstract 1
- 239000003960 organic solvent Substances 0.000 abstract 1
- 238000000746 purification Methods 0.000 abstract 1
- 229910052708 sodium Inorganic materials 0.000 abstract 1
- 239000011734 sodium Substances 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 abstract 1
- -1 sulphuric Chemical class 0.000 abstract 1
- 150000003567 thiocyanates Chemical class 0.000 abstract 1
- YWYZEGXAUVWDED-UHFFFAOYSA-N triammonium citrate Chemical class [NH4+].[NH4+].[NH4+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O YWYZEGXAUVWDED-UHFFFAOYSA-N 0.000 abstract 1
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical class OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Abstract
Heparin is recovered from an alkaline or substantially neutral aqueous solution containing also a protein by adding a soluble salt of an alkali metal, or of ammonium, or of an alkaline earth metal to said solution, acidifying the solution to precipitate the protein, removing the protein and recovering the heparin from the remaining solution. The solution of the proteinheparin mixture may have a pH between 7 and 10. Sufficient soluble salt may be added to produce an anion concentration of at least about one mol. per litre. Suitable salts which may be used are alkali metal and ammonium citrates, halides, acetates, sulphates and thiocyanates, and alkaline earth metal halides, acetates and citrates, e.g. sodium chloride, sodium thiocyante, calcium chloride and acetate, and ammonium sulphate and citrate may be used. When sodium chloride is used, the solution may be acidified to a pH of less than 4, e.g. when between about 100 grams and about 150 grams of sodium chloride is used, the solution may be acidified to a pH of about 2.5 to precipitate the protein. The heparin solution containing protein may be obtained by autolyzing heparinbearing animal tissue, extracting the autolyzed tissue with an aqueous solution of alkali, e.g. ammonium sulphate and sodium hydroxide, heating the mixture, filtering to remove the coagulated substance, acidifying to precipitate a protein-heparin complex which is dissolved in water at a pH of at least 7 to form the solution for the above process. The process is applicable to heparin mixtures containing denatured or native proteins. The temperature at which protein coagulation is effected may vary from about 0 DEG C. to about 100 DEG C.-heating during or after the acidification being particularly useful. Suitable acids which may be used for the acidification are strong inorganic and strong organic acids such as sulphuric, hydrochloric and trichloroacetic acids. The heparin is preferably precipitated from the protein-free solution by adding a water-miscible organic solvent such as methyl or ethyl alcohol or acetone. When the soluble salt used in the above process is not very soluble in ethyl alcohol or acetone, it is desirable to subject the filtrate to dialysis to remove the salt before the heparin is precipitated. Alternatively, the precipitated heparin containing the salt may be dissolved in water, the solution subjected to dialysis to remove the salt, and reprecipitating the heparin with alcohol or acetone. The process is suitable for the purification of heparin, e.g. impure heparin can be mixed with an acid precipitable protein such as casein, the mixture is acidified and the resulting precipitated heparin-protein complex can then be treated by the above process. A number of detailed examples are given. U.S.A. Specification 2,623,001 is referred to.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US754885XA | 1953-07-01 | 1953-07-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB754885A true GB754885A (en) | 1956-08-15 |
Family
ID=22126091
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB18577/54A Expired GB754885A (en) | 1953-07-01 | 1954-06-24 | Recovery of heparin |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB754885A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105399865A (en) * | 2014-09-16 | 2016-03-16 | 东营天东制药有限公司 | Efficient heparin sodium bulk drug refining process |
CN115286725A (en) * | 2022-08-31 | 2022-11-04 | 山东万邦赛诺康生化制药股份有限公司 | Preparation method of high-purity low-molecular-weight heparin |
-
1954
- 1954-06-24 GB GB18577/54A patent/GB754885A/en not_active Expired
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105399865A (en) * | 2014-09-16 | 2016-03-16 | 东营天东制药有限公司 | Efficient heparin sodium bulk drug refining process |
CN115286725A (en) * | 2022-08-31 | 2022-11-04 | 山东万邦赛诺康生化制药股份有限公司 | Preparation method of high-purity low-molecular-weight heparin |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109096161B (en) | Preparation method of N-acetylcysteine | |
US3936375A (en) | Process for dewatering a proteinaceous, aqueous sludge and for removing and recovering precipitating agents from a precipitate containing proteinaceous substances | |
US3936351A (en) | Method for preparing glucoronyl-glucosamino-glycan sulphates exhibiting antilipasaemic activity | |
GB754885A (en) | Recovery of heparin | |
US2710858A (en) | Making ferrilactin | |
US2797184A (en) | Process for the recovery of heparin | |
US3518243A (en) | Sulfonated derivatives of a glycopeptide extracted from animal organs,useful as drugs and a process for the preparation thereof | |
US2009868A (en) | Method of preparing leucine | |
US2549526A (en) | Process for recovery of vegetable protein | |
KR820001739B1 (en) | Process for the recovery of heparin | |
CA1054896A (en) | Process for removing and recovering precipitation agents from precipitate containing proteinous substances | |
FI65073B (en) | FOERFARANDE FOER FRAMSTAELLNING AV HEPARIN | |
US2826571A (en) | Protein product and process | |
GB751287A (en) | Improvements in or relating to process of preparing amino acids | |
SU531476A3 (en) | The method of obtaining albumin and whey proteins | |
GB872214A (en) | Extraction process for the recovery of heparin | |
GB816281A (en) | Coagulation of lignin in aqueous suspension | |
DE950594C (en) | Method for obtaining heparin | |
Robson et al. | A new technique for the estimation and isolation of the hexone bases in protein hydrolysates | |
GB906819A (en) | Parenteral solution for diagnostic test of cancer and a process of preparing same | |
US2166133A (en) | Therapeutically valuable gold compounds and a method for producing the same | |
GB1239861A (en) | Improvements in or relating to the production of collagen and/or gelatine | |
US2723291A (en) | Treatment of glutamic acid-containing hydrolysates | |
GB428584A (en) | Improvements relating to processes for the treatment of lime aluminates | |
GB410649A (en) | Process of preparing purified mucins and solutions thereof |